⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20992224 | 0.82 | — | — | |
| SCHEMBL19487963 | 0.82 | — | — | |
| SCHEMBL18594713 | 0.80 | MEN1 (0.31) | — | |
| SCHEMBL26836478 | 0.78 | — | — | |
| SCHEMBL18594710 | 0.78 | CA2 (0.31) | — | |
| SCHEMBL26153445 | 0.77 | GRIK1 (0.33) | — | |
| SCHEMBL26153413 | 0.77 | — | — | |
| SCHEMBL20870229 | 0.73 | MAOB (0.30) | — | |
| SCHEMBL23801160 | 0.71 | — | — | |
| SCHEMBL24877021 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10626144-B2 | Peptide derivatives and uses thereof | NOSOPHARM (FR) | 2020-04-21 | — | — | US | disclosed |
| US-20170298097-A1 | Peptide Derivatives and Uses Thereof | NOSOPHARM (FR) | 2017-10-19 | — | — | US | disclosed |